Full-Time

Associate Director

Field Medical Affairs-Hematology

Posted on 1/17/2025

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

10,001+ employees

Develops medicines for serious diseases

Biotechnology
Healthcare

Compensation Overview

$173.5k - $283.1kAnnually

Senior, Expert

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Terminal scientific degree (MD, PharmD, or PhD) required
  • 8+ years of experience
  • Minimum of 4 years experience within a Hematology/Oncology Medical Science Liaison function required
  • Knowledge of treatment guidelines, clinical research processes, FDA regulations, pharma regulations/compliant practices, and OIG guidelines
Responsibilities
  • Identifying and maintaining a list of medical/therapeutic area experts, investigator targets and associated plans of action
  • Establishing, fostering, cultivating and maintaining relationships with KOLs in Hematological Malignancies
  • Act as the primary clinical/scientific resource for information pertaining to disease state and our products ensuring awareness and understanding
  • Participates in the development and management of company sponsored clinical trials
  • Establishing scientific relationship with investigators and internal Medical Affairs, supporting investigator-initiated study (IIS) concept program
  • Identifying relevant insights on research developments, treatment landscape to shape medical strategy
  • Identifies gaps in research needs and creates opportunities by collaborating with potential and existing investigators and site personnel
  • Responds to requests for information related to study indications, disease state and therapeutic area, and presents/discusses scientific/clinical data
  • Attends medical conferences collecting and reporting relevant, scientific, clinical, & competitive intelligence
  • Ensures company policies, procedures, principles and financial controls are maintained with integrity and professionalism is displayed internally and externally
Desired Qualifications
  • Established relationships with KOLs and institutions focused on Hematologic Malignancies
  • Drug launch experience
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

View

Regeneron Pharmaceuticals develops medicines aimed at treating serious diseases such as cancer, eye diseases, and allergic conditions. The company uses its own technologies and extensive research to create new therapies, often collaborating with academic institutions and other pharmaceutical companies to enhance its development efforts. Unlike many competitors, Regeneron focuses on both research and commercialization, generating revenue through the sale of its approved medicines and licensing its technologies. The goal of Regeneron is to improve patient outcomes by providing effective treatments and ensuring that its products meet high safety and efficacy standards.

Company Stage

IPO

Total Funding

$684M

Headquarters

Town of Greenburgh, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • Regeneron's investment in Truveta enhances its genomic data capabilities for personalized medicine.
  • The Oxular acquisition expands Regeneron's portfolio in retinal disorder treatments.
  • Dupixent's FDA review for CSU could open a new revenue stream for Regeneron.

What critics are saying

  • Class action lawsuits may lead to financial liabilities and reputational damage.
  • Investment in Truveta may not yield expected financial returns.
  • Competition from AstraZeneca and Amgen could impact Regeneron's market share.

What makes Regeneron Pharmaceuticals unique

  • Regeneron leverages proprietary technologies for innovative treatments in serious diseases.
  • The company collaborates with academic and research institutions to enhance R&D efforts.
  • Regeneron's strategic partnerships enable shared costs and profits in new treatment development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Wellness Program

Paid Vacation

Equity Awards

Annual Bonuses

Flexible Work Hours